Canada markets closed

MYGN Aug 2022 28.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
3.50000.0000 (0.00%)
As of 12:08PM EDT. Market open.
Full screen
Previous Close3.5000
Expire Date2022-08-19
Day's Range3.5000 - 3.5000
Contract RangeN/A
Open Interest6
  • Zacks

    Myriad Genetics (MYGN) Reports Loss in Q1, Gross Margin Down

    Myriad Genetics' (MYGN) sales in the majority of the operating segments improved in the first quarter despite a challenging business environment.

  • Zacks

    Myriad Genetics (MYGN) Reports Q1 Loss, Tops Revenue Estimates

    Myriad (MYGN) delivered earnings and revenue surprises of 40% and 3.98%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Myriad Genetics Reports First Quarter Revenue and Reiterates Guidance for 2022

    Highlights: Revenue of $164.9 million for the quarter ended March 31, 2022 Excluding revenue from divested businesses, revenue increased 11% year-over-year Diluted GAAP earnings per share (EPS) of $(0.26) and adjusted EPS of $(0.03) in the first quarter of 2022 improved by $0.26 and $0.03 year-over-year, respectivelyEnded the quarter with $339.2 million in cash, cash equivalents and investmentsNew partnership with Intermountain Precision Genomics to launch Precise™ Liquid Biopsy Therapy Selectio